It is very important to follow these instructions to achieve good efficacy of the medication in the ear. When applying the drops to the ear, it is not recommended to keep your head vertical or move it too quickly, as some drops may spill down your face and not penetrate the ear canal.
Avoid letting the dropper come into contact with your ears or fingers to limit the risk of contamination of the drops.
After completing treatment, dispose of the remaining bottle and do not store it for reuse.
If you use more CIPROXINA than you should, do not apply more drops until the next dose.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to use CIPROXINA,apply a single dose as soon as you remember, and continue with the next dose scheduled. However, if it is almost time for the next dose, do not apply the missed dose and continue with the next dose of your regular regimen. Do not apply a double dose to compensate for the missed doses.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, CIPROXINA may produce adverse effects, although not everyone will experience them.
The following adverse effects have been observed with CIPROXINA:
Frequent
(may affect up to 1 in 10 people)
Ear effects: ear itching.
Rare
(may affect up to 1 in 100 people)
Ear effects: ear pain, ear congestion, ear discomfort, ear canal redness.
Other effects: dizziness, headache, nausea, skin peeling, fungal skin infection, urticaria, skin rash, itching, abnormal or decreased skin sensation, and presence of medication residue inside or around the ear.
Additional adverse effects were reported for whichfrequency is unknown(cannot be estimated from available data), including:
Ear effects: reduced hearing, tinnitus.
Eye effects:blurred vision
Other effects: allergy.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the bottle and on the box after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above 25°C.
Do not refrigerate or freeze.
Store the container within the box to protect it from light.
Keep the container perfectly closed to protect it from moisture.
Once the bottle is opened and the dropper is placed, the drops must be used within the next 14 days.
After completing the treatment, dispose of the remaining contents of the bottle. Do not store it for use on other occasions.
Medications should not be thrown away through the drains or in the trash. Deposit the containers and medications that you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications that you no longer need. In this way, you will help protect the environment.
CIPROXINA Composition
Appearance of the product and contents of the packaging
CIPROXINA is a white to off-white liquid (a suspension). It is presented in a box containing a 10 ml glass vial with a polypropylene screw cap and, separately, a dropper (polypropylene pipette, a polypropylene cap, and a latex rubber cap).
Marketing Authorization Holder
Novartis Farmacéutica, S.A.
Gran Via de les Corts Catalanes, 764
08013 - Barcelona, Spain
Responsible for Manufacturing
Siegfried El Masnou, S.A
C/Camil Fabra, 58
08320 El Masnou – Barcelona
or
Novartis Farmacéutica S.A.
Gran Via de les Corts Catalanes, 764
08013 Barcelona, Spain
or
Novartis Pharma GmbH
Roonstrasse 25
90429 Nuremberg, Germany
Last review date of this leaflet: September 2020
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS):http://www.aemps.gob.es
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.